-

Abond CRO Hires Charley Bratton as Senior Vice President Corporate Marketing and Sales

ALLENDALE, Mich.--(BUSINESS WIRE)--Abond CRO Inc. announced today the hiring of Mr. Charley Bratton as Senior Vice President Corporate Marketing and Sales. This is a new position for the company and is a direct result of the growth and development the organization has experienced over the past few years.

According to Dr. Phil Doren, CEO, “Mr. Bratton will lead an array of activities contributing to the company’s plans for accelerated growth and expansion of service offerings.”

“Abond CRO is excited to have Charley join our company. He brings years of sales and marketing experience, industry-wide knowledge and an incredible amount of energy to this role. He is well-respected in the industry for providing client service excellence to meet drug and device development needs. Charley will add to the leadership team that we have in place to serve our pharmaceutical, biotech and medical device customers. His leadership experience and industry expertise in business development and marketing greatly enhances our organizational capability to provide excellent support in those areas to our customers,” Doren added.

About Abond CRO Inc. (www.abondcro.com)

Abond is a full-service clinical research organization dedicated to providing specialized clinical research support for the pharmaceutical and medical device industries since its founding in 1974 (incorporation in 1985). They deliver everything you’d expect from a full-service CRO — consulting, clinical operations, data management, statistical analysis — and a few things that set them apart: honesty, focus, and responsibility. Abond works with small startup organizations to established pharmaceutical and medical device leaders around the world.

Contacts

Abond CRO Inc.
Charley Bratton
919-316-8111
cbratton@abondcro.com

Abond CRO Inc.

Details
Headquarters: Allendale, MI
CEO: Phil Doren
Employees: 64
Organization: PRI

Release Versions

Contacts

Abond CRO Inc.
Charley Bratton
919-316-8111
cbratton@abondcro.com

Social Media Profiles
More News From Abond CRO Inc.

ADDING MULTIMEDIA Danita Harris Joins Abond CRO as Executive Director, Clinical Data Management

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, CEO and Vice President, is pleased to announce that Danita Harris has joined Abond CRO as Executive Director, Data Management. Ms. Harris brings 23 years of research experience, with most of that time in Data Management. Early in her career, Danita led individual studies and then moved up through to DM Leadership. Her expertise includes DM account management with small, mid, and large pharma companies, including establishing new working partner...

Abond CRO Announces That Mr. Zoran Antonijevic Is Their New Vice President, Statistical Consulting

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer and Vice President, is pleased to announce today that Zoran Antonijevic is the Vice President, Statistical Consulting at Abond CRO Inc. “With this single appointment, we have greatly strengthened our capability to address customers’ needs in statistical consulting for drug development,” Doren said. Mr. Antonijevic is an industry thought leader with cutting edge knowledge of innovative methods and strategies including ada...

Abond CRO Announces that Dr. Susan Walker is a Member of Board of Directors

ALLENDALE, Mich.--(BUSINESS WIRE)--Dr. Phil Doren, Chief Executive Officer, announced today that Dr. Susan Walker is a member of the Board of Directors of Abond CRO Inc. Dr. Walker is an independent consultant and the immediate past director of the Division of Dermatology and Dental Products (DDDP) at the US Food and Drug Administration (FDA). From 2006 to 2014 she led this division of over 40 senior physicians, scientists, and staff with responsibilities for review and approval of regulatory a...
Back to Newsroom